Optinose Announces Inducement Grants

Optinose

YARDLEY, PA — OptiNose, Inc. (NASDAQ: OPTN) this week announced that the company has granted non-qualified stock option awards to purchase an aggregate of 54,000 shares of its common stock to three new employees as an inducement material for accepting employment with OptiNose. The stock option awards were granted outside of the OptiNose, Inc. 2010 Stock Incentive Plan in accordance with Nasdaq Listing Rule 5635(c)(4).

The stock options were granted to the new employees on their hire date April 17, 2023, with an exercise price of $2.05 which is equal to the closing price of the company’s common stock as reported by Nasdaq on the grant date.

The stock options have a 10-year term and vest over four years, with one-fourth of the shares underlying the stock option vesting on the first anniversary of the grant date and the remainder vesting in thirty-six equal monthly installments thereafter. Vesting of the stock options is subject to continued service with the company through the applicable vesting date.

For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.

READ:  Windtree Therapeutics Continues to Advance in Market with Ambitious Strategies; Reports Financial Results of Q4 and Fiscal Year 2023